Synapticure Inc.
Kenilworth, IL
- UEI
- G9QUJCDRVYB7
- CAGE
- 8PUS5
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 618 Melrose Ave, Kenilworth, IL 60043, USA
- Website
- synapticure.com
- Founded
- 2019
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- Health Care Services
- SIC code
- 80 Health Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| 3D in vitro model of genetic and sporadic FTD: accelerating novel therapeutic development - abstract up to 60,000… | National Institute of Neurological Disorders and Stroke | $3,753,246 | |
| Mature brain organoid platform for therapeutic screening for ALS/FTD - abstract synapticure is developing a novel… | National Institute of Neurological Disorders and Stroke | $1,499,997 | |
| Novel patient-derived 3D platform for detecting TDP-43 proteinopathy and associated biomarkers for ALS/FTD - abstract… | National Institute of Neurological Disorders and Stroke | $6,693,962 |
About Synapticure Inc.
Synapticure Inc. is a for-profit corporate entity registered in SAM.gov since August 2020, located in Kenilworth, Illinois. The company specializes in developing advanced neurological research platforms, specifically focusing on creating innovative 3D in vitro models for neurodegenerative disease research. Their primary technological focus appears to be on developing sophisticated brain organoid systems that can model complex cellular interactions, particularly for conditions like Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). These platforms are designed to provide high-fidelity modeling and screening of disease-specific proteinopathies and biomarkers, addressing critical gaps in current neurological research methodologies.
Through federal grant awards, primarily from the National Institute of Neurological Disorders and Stroke and the National Institute on Aging, Synapticure has been developing patient-derived 3D platforms for modeling neurodegenerative diseases. Their grants, including R44NS143521, R43NS134458, and R44NS124457, focus on creating advanced brain organoid systems like Cortical Brain Spheroids (CBS) and Massembloids that can recapitulate key disease features of ALS and FTD. The company has been awarded substantial funding, including a $2.5 million grant to develop 3D in vitro models for frontotemporal dementia. Additionally, they have engaged in a sub-award with Columbia University for an expanded access protocol for ALS patients, demonstrating their commitment to translational research. Their work involves generating complex cellular models using induced pluripotent stem cells, evaluating disease-specific markers like TDP-43 proteinopathy, and developing platforms for potential therapeutic screening and biomarker identification.
Quick answers
What is Synapticure Inc.'s UEI?
Synapticure Inc.'s Unique Entity ID (UEI) in SAM.gov is G9QUJCDRVYB7.
What is Synapticure Inc.'s CAGE code?
Synapticure Inc.'s CAGE code is 8PUS5.
What is Synapticure Inc.'s primary NAICS code?
Synapticure Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Synapticure Inc. located?
Synapticure Inc.'s physical address in SAM.gov is 618 Melrose Ave, Kenilworth, IL 60043, USA.
Is Synapticure Inc. registered in SAM.gov?
Yes. Synapticure Inc.'s SAM.gov registration is active through October 17, 2026.
What is Synapticure Inc.'s most recent federal award?
Synapticure Inc.'s most recent federal grant award is 3D in vitro model of genetic and sporadic FTD: accelerating novel therapeutic development - abstract up to 60,000… (R44NS143521), from National Institute of Neurological Disorders and Stroke, on May 9, 2025.
On GovTribe
See Synapticure Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors